Laughrea, P.-A. and Hébert, M. 2022. Staying ahead of dupilumab-associated ocular surface disease. Canadian Eye Care Today. 1, 2 (Sep. 2022), 8–13. DOI:https://doi.org/10.58931/cect.2022.1212.